Bendopnea, a symptom indicating shortness of breath when bending forward, was studied in patients with severe obstructive sleep apnea syndrome (OSAS) to understand its prevalence and characteristics.
In a group of 95 patients, 34.7% experienced bendopnea, with an average age of 62 and a high prevalence of obesity (BMI of 34 kg/m²).
The presence of bendopnea was significantly associated with older age, obesity, heart failure, and other respiratory diseases, signaling a need for further attention to these patients' health issues.
* The introduction of iPCSK9 medications allowed some patients to stop lipoapheresis while still maintaining healthy cholesterol levels.
* A case study of a 27-year-old male with Congenital Muscular Dystrophy and Heterozygous Familial Hypercholesterolemia showed successful treatment with alirocumab, reducing cLDL levels effectively after discontinuing lipoapheresis.
* Among 250 DHF patients, 48.8% experienced bendopnea, which correlated with worse symptoms and functional class, including higher rates of other breathing problems and edema.
* Bendopnea was found to significantly impact QoL, with many patients facing moderate to severe limitations, and was linked to a higher mortality rate and advanced heart failure stages.
PCT (Procalcitonin) is an important diagnostic tool for bacterial infections, but its effectiveness in elderly patients had not been extensively studied prior to this research.*
-
The study involved 161 elderly patients (75 years and older) split into two groups: one with probable bacterial infections and another with noninfectious diseases, to assess the validity of PCT levels in diagnosis.*
-
Results showed that PCT had a sensitivity of 72% and specificity of 92% for diagnosing bacterial infections in the elderly, indicating it can effectively help identify infections in this population.*